Caribou Biosciences

Caribou Biosciences

Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.

All edits by  Dan Rummel 

Edits on 27 Jul 2018
Dan Rummel
Dan Rummel edited on 27 Jul 2018 3:42 am
Edits made to:
Article (+10/-10 characters)


There is a patent dispute between Doudna’s research team and the Broad Institute (MIT and Harvard) over the invention of CRISPR-Cas9 technology for use in human cells. The US patent granted to the Broad Institute is under appeal. The European patent office has revoked this first patent obtained by the Broad Institute citing lack of novelty. The European patent office has granted patents to the University of CaliforniaCalifornia and University of Vienna. One for using the CRISPR-Cas9 system across prokaryotic and eukaryotic systems and another for a modified form of CRISPR-Cas9 to regulate gene expression. Numerous patents have been assigned to Caribou Biosciences for CRISPR-Cas9 adaptations and other molecular biology materials.

No more activity to show.